Skip to content

Supporting Decisions on Lifestyle Change

Increasing Initiation of Evidence-based Weight Loss Treatment

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06206954
Enrollment
864
Registered
2024-01-16
Start date
2024-01-24
Completion date
2028-07-30
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

initiation, recruitment, engagement, behavioral intervention

Brief summary

This study will test the effects of a brief, individually tailored intervention aiming to increase initiation of comprehensive behavioral weight loss treatment on weight.

Interventions

BEHAVIORALMyHealthPath Tool

Tailored, brief online tool to help patients learn about weight treatment options

BEHAVIORALMyHealthPath Guide

Informational material to help patients learn about weight treatment options

Sponsors

University of Florida
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigators (with exception of statistician) will be masked to study condition. Outcome assessors and all staff engaging directly with participants will be masked to study condition, except those staff who are sending intervention content.

Intervention model description

Parallel cluster randomized

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Body Mass Index (BMI) ≥ 30 kg/m2 based on self-report body weight and height, or BMI ≥ 27-29.9 kg/m2 with a weight related comorbidity of hypertension, type 2 diabetes, pre-diabetes, dyslipidemia, or obstructive sleep apnea, gastroesophageal reflux disease, or coronary artery disease. * Self-report weight ≤ 375 lbs (the maximum weight that BodyTrace scales can accurately detect is 397 lbs, thus 375 lbs provides a buffer to allow detection of at least 20 lbs weight gain). * Has a desire to weigh less * Has valid email address in Electronic Health Record * Has an appointment scheduled with enrolled PCP about 21-28 days after electronic data pull * Speaks and reads English * Has either WiFi internet access at home or a phone or tablet with a data plan.

Exclusion criteria

* Currently enrolled in evidence-based comprehensive weight loss treatment * Pregnant or planning to become pregnant in the next 6 months * Currently breastfeeding (or pumping breastmilk) more than 3 times per day. * Currently undergoing treatment for cancer * Had cardiovascular event in the past 60 days * Severe depression symptoms on PHQ-8 (total score ≥20) * Inpatient psychiatric treatment in the past 6 months * Eating disorder in past 5 years * Congestive heart failure resulting in recent (past 6 months) hospitalization or contributing to difficulty breathing or difficulty doing daily activities. * Dementia diagnosis * Bariatric surgery in the past year or currently undergoing evaluation for bariatric surgery * Currently taking doctor-prescribed medication for weight loss * Inability to stand on body weight scale independently * Impaired hearing * Unable to read content on websites without assistance

Design outcomes

Primary

MeasureTime frameDescription
Proportion initiating treatmentWithin 2 months of PCP appointment dateAttend at least one intervention session of comprehensive behavioral weight loss intervention. Documented by interventionist/program.

Secondary

MeasureTime frameDescription
Number of treatment sessions attended6 monthsTotal number of attended intervention session of comprehensive behavioral weight loss intervention. Documented by interventionist/program.
Proportion discussing weight-related topic with PCPat completion of PCP visit (occuring up to 4 weeks after enrollment)Per patient self-report, discussed weight, diet, or physical activity with PCP at index PCP visit.
Proportion achieving 5% weight loss6 monthsProportion of participants losing 5% of their baseline weight between baseline and 6 months
Percent weight loss6 monthsPercent weight loss from baseline to 6 months

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMegan A McVay, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026